Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
31,654
archived clinical trials in
Cardiology

Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Cardiovascular Outcomes Following Treatment With Alogliptin in Addition to Standard of Care in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Status: Enrolling
Updated:  1/28/2013
Clinical Research Facility
mi
from
Dallas, TX
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Cardiovascular Outcomes Following Treatment With Alogliptin in Addition to Standard of Care in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Status: Enrolling
Updated: 1/28/2013
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Cardiovascular Outcomes Following Treatment With Alogliptin in Addition to Standard of Care in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Status: Enrolling
Updated:  1/28/2013
Clinical Research Facility
mi
from
Salt Lake City, UT
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Cardiovascular Outcomes Following Treatment With Alogliptin in Addition to Standard of Care in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Status: Enrolling
Updated: 1/28/2013
Clinical Research Facility
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Cardiovascular Outcomes Following Treatment With Alogliptin in Addition to Standard of Care in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Status: Enrolling
Updated:  1/28/2013
Clinical Research Facility
mi
from
Burlington, VT
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Cardiovascular Outcomes Following Treatment With Alogliptin in Addition to Standard of Care in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Status: Enrolling
Updated: 1/28/2013
Clinical Research Facility
mi
from
Burlington, VT
Click here to add this to my saved trials
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Cardiovascular Outcomes Following Treatment With Alogliptin in Addition to Standard of Care in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Status: Enrolling
Updated:  1/28/2013
Clinical Research Facility
mi
from
Norfolk, VA
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Cardiovascular Outcomes Following Treatment With Alogliptin in Addition to Standard of Care in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Status: Enrolling
Updated: 1/28/2013
Clinical Research Facility
mi
from
Norfolk, VA
Click here to add this to my saved trials
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Cardiovascular Outcomes Following Treatment With Alogliptin in Addition to Standard of Care in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Status: Enrolling
Updated:  1/28/2013
Clinical Research Facility
mi
from
Seattle, WA
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Cardiovascular Outcomes Following Treatment With Alogliptin in Addition to Standard of Care in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Status: Enrolling
Updated: 1/28/2013
Clinical Research Facility
mi
from
Seattle, WA
Click here to add this to my saved trials
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Cardiovascular Outcomes Following Treatment With Alogliptin in Addition to Standard of Care in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Status: Enrolling
Updated:  1/28/2013
Clinical Research Facility
mi
from
Milwaukee, WI
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Cardiovascular Outcomes Following Treatment With Alogliptin in Addition to Standard of Care in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Status: Enrolling
Updated: 1/28/2013
Clinical Research Facility
mi
from
Milwaukee, WI
Click here to add this to my saved trials
A Study to Assess the Pharmacokinetics, Safety and Tolerability of Repeat Oral Doses of Darapladib (SB-480848) in Subjects With Severe Renal Impairment
An Open-Label, Non-Randomized, Pharmacokinetic and Safety Study of Multiple Oral Doses of SB-480848 in Healthy Subjects and in Subjects With Severe Renal Impairment
Status: Enrolling
Updated:  1/31/2013
GSK Investigational Site
mi
from
Jacksonville, FL
A Study to Assess the Pharmacokinetics, Safety and Tolerability of Repeat Oral Doses of Darapladib (SB-480848) in Subjects With Severe Renal Impairment
An Open-Label, Non-Randomized, Pharmacokinetic and Safety Study of Multiple Oral Doses of SB-480848 in Healthy Subjects and in Subjects With Severe Renal Impairment
Status: Enrolling
Updated: 1/31/2013
GSK Investigational Site
mi
from
Jacksonville, FL
Click here to add this to my saved trials
A Study to Assess the Pharmacokinetics, Safety and Tolerability of Repeat Oral Doses of Darapladib (SB-480848) in Subjects With Severe Renal Impairment
An Open-Label, Non-Randomized, Pharmacokinetic and Safety Study of Multiple Oral Doses of SB-480848 in Healthy Subjects and in Subjects With Severe Renal Impairment
Status: Enrolling
Updated:  1/31/2013
GSK Investigational Site
mi
from
Rochester, MN
A Study to Assess the Pharmacokinetics, Safety and Tolerability of Repeat Oral Doses of Darapladib (SB-480848) in Subjects With Severe Renal Impairment
An Open-Label, Non-Randomized, Pharmacokinetic and Safety Study of Multiple Oral Doses of SB-480848 in Healthy Subjects and in Subjects With Severe Renal Impairment
Status: Enrolling
Updated: 1/31/2013
GSK Investigational Site
mi
from
Rochester, MN
Click here to add this to my saved trials
A Pharmacodynamic Study With Ticagrelor in Hispanic Patients
A Randomized, Open-Label, Multiple Dose, Crossover, Multiple Center Study of the Antiplatelet Effects of Ticagrelor Versus Clopidogrel in Hispanic Patients With Stable Coronary Artery Disease
Status: Enrolling
Updated:  2/4/2013
Clinical Research Facility
mi
from
San Diego, CA
A Pharmacodynamic Study With Ticagrelor in Hispanic Patients
A Randomized, Open-Label, Multiple Dose, Crossover, Multiple Center Study of the Antiplatelet Effects of Ticagrelor Versus Clopidogrel in Hispanic Patients With Stable Coronary Artery Disease
Status: Enrolling
Updated: 2/4/2013
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
A Pharmacodynamic Study With Ticagrelor in Hispanic Patients
A Randomized, Open-Label, Multiple Dose, Crossover, Multiple Center Study of the Antiplatelet Effects of Ticagrelor Versus Clopidogrel in Hispanic Patients With Stable Coronary Artery Disease
Status: Enrolling
Updated:  2/4/2013
Clinical Research Facility
mi
from
Fort Lauderdale, FL
A Pharmacodynamic Study With Ticagrelor in Hispanic Patients
A Randomized, Open-Label, Multiple Dose, Crossover, Multiple Center Study of the Antiplatelet Effects of Ticagrelor Versus Clopidogrel in Hispanic Patients With Stable Coronary Artery Disease
Status: Enrolling
Updated: 2/4/2013
Clinical Research Facility
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
A Pharmacodynamic Study With Ticagrelor in Hispanic Patients
A Randomized, Open-Label, Multiple Dose, Crossover, Multiple Center Study of the Antiplatelet Effects of Ticagrelor Versus Clopidogrel in Hispanic Patients With Stable Coronary Artery Disease
Status: Enrolling
Updated:  2/4/2013
Clinical Research Facility
mi
from
Baltimore, MD
A Pharmacodynamic Study With Ticagrelor in Hispanic Patients
A Randomized, Open-Label, Multiple Dose, Crossover, Multiple Center Study of the Antiplatelet Effects of Ticagrelor Versus Clopidogrel in Hispanic Patients With Stable Coronary Artery Disease
Status: Enrolling
Updated: 2/4/2013
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Pharmacodynamic Study With Ticagrelor in Hispanic Patients
A Randomized, Open-Label, Multiple Dose, Crossover, Multiple Center Study of the Antiplatelet Effects of Ticagrelor Versus Clopidogrel in Hispanic Patients With Stable Coronary Artery Disease
Status: Enrolling
Updated:  2/4/2013
Clinical Research Facility
mi
from
Teaneck, NJ
A Pharmacodynamic Study With Ticagrelor in Hispanic Patients
A Randomized, Open-Label, Multiple Dose, Crossover, Multiple Center Study of the Antiplatelet Effects of Ticagrelor Versus Clopidogrel in Hispanic Patients With Stable Coronary Artery Disease
Status: Enrolling
Updated: 2/4/2013
Clinical Research Facility
mi
from
Teaneck, NJ
Click here to add this to my saved trials
A Pharmacodynamic Study With Ticagrelor in African American Patients
A Randomized, Open-Label, Multiple Dose, Crossover, Multiple Center Study of the Antiplatelet Effects of Ticagrelor Versus Clopidogrel in African American Patients With Stable Coronary Artery Disease
Status: Enrolling
Updated:  2/4/2013
Clinical Research Facility
mi
from
Newark, DE
A Pharmacodynamic Study With Ticagrelor in African American Patients
A Randomized, Open-Label, Multiple Dose, Crossover, Multiple Center Study of the Antiplatelet Effects of Ticagrelor Versus Clopidogrel in African American Patients With Stable Coronary Artery Disease
Status: Enrolling
Updated: 2/4/2013
Clinical Research Facility
mi
from
Newark, DE
Click here to add this to my saved trials
A Pharmacodynamic Study With Ticagrelor in African American Patients
A Randomized, Open-Label, Multiple Dose, Crossover, Multiple Center Study of the Antiplatelet Effects of Ticagrelor Versus Clopidogrel in African American Patients With Stable Coronary Artery Disease
Status: Enrolling
Updated:  2/4/2013
Clinical Research Facility
mi
from
Washington,
A Pharmacodynamic Study With Ticagrelor in African American Patients
A Randomized, Open-Label, Multiple Dose, Crossover, Multiple Center Study of the Antiplatelet Effects of Ticagrelor Versus Clopidogrel in African American Patients With Stable Coronary Artery Disease
Status: Enrolling
Updated: 2/4/2013
Clinical Research Facility
mi
from
Washington,
Click here to add this to my saved trials
A Pharmacodynamic Study With Ticagrelor in African American Patients
A Randomized, Open-Label, Multiple Dose, Crossover, Multiple Center Study of the Antiplatelet Effects of Ticagrelor Versus Clopidogrel in African American Patients With Stable Coronary Artery Disease
Status: Enrolling
Updated:  2/4/2013
Clinical Research Facility
mi
from
Fort Lauderdale, FL
A Pharmacodynamic Study With Ticagrelor in African American Patients
A Randomized, Open-Label, Multiple Dose, Crossover, Multiple Center Study of the Antiplatelet Effects of Ticagrelor Versus Clopidogrel in African American Patients With Stable Coronary Artery Disease
Status: Enrolling
Updated: 2/4/2013
Clinical Research Facility
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
A Pharmacodynamic Study With Ticagrelor in African American Patients
A Randomized, Open-Label, Multiple Dose, Crossover, Multiple Center Study of the Antiplatelet Effects of Ticagrelor Versus Clopidogrel in African American Patients With Stable Coronary Artery Disease
Status: Enrolling
Updated:  2/4/2013
Clinical Research Facility
mi
from
Atlanta, GA
A Pharmacodynamic Study With Ticagrelor in African American Patients
A Randomized, Open-Label, Multiple Dose, Crossover, Multiple Center Study of the Antiplatelet Effects of Ticagrelor Versus Clopidogrel in African American Patients With Stable Coronary Artery Disease
Status: Enrolling
Updated: 2/4/2013
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Pharmacodynamic Study With Ticagrelor in African American Patients
A Randomized, Open-Label, Multiple Dose, Crossover, Multiple Center Study of the Antiplatelet Effects of Ticagrelor Versus Clopidogrel in African American Patients With Stable Coronary Artery Disease
Status: Enrolling
Updated:  2/4/2013
Clinical Research Facility
mi
from
Baltimore, MD
A Pharmacodynamic Study With Ticagrelor in African American Patients
A Randomized, Open-Label, Multiple Dose, Crossover, Multiple Center Study of the Antiplatelet Effects of Ticagrelor Versus Clopidogrel in African American Patients With Stable Coronary Artery Disease
Status: Enrolling
Updated: 2/4/2013
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Pharmacodynamic Study With Ticagrelor in African American Patients
A Randomized, Open-Label, Multiple Dose, Crossover, Multiple Center Study of the Antiplatelet Effects of Ticagrelor Versus Clopidogrel in African American Patients With Stable Coronary Artery Disease
Status: Enrolling
Updated:  2/4/2013
Clinical Research Facility
mi
from
Houston, TX
A Pharmacodynamic Study With Ticagrelor in African American Patients
A Randomized, Open-Label, Multiple Dose, Crossover, Multiple Center Study of the Antiplatelet Effects of Ticagrelor Versus Clopidogrel in African American Patients With Stable Coronary Artery Disease
Status: Enrolling
Updated: 2/4/2013
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Effects of a High Protein Diet on Clinical Outcomes in Heart Failure
Examining the Effects of a High Protein Diet on Adiposity and Cardiac Structure in Patients With Heart Failure, Obesity, and Diabetes Mellitus
Status: Enrolling
Updated:  2/6/2013
University of California Medical Center
mi
from
Orange, CA
Effects of a High Protein Diet on Clinical Outcomes in Heart Failure
Examining the Effects of a High Protein Diet on Adiposity and Cardiac Structure in Patients With Heart Failure, Obesity, and Diabetes Mellitus
Status: Enrolling
Updated: 2/6/2013
University of California Medical Center
mi
from
Orange, CA
Click here to add this to my saved trials
To Estimate the Potential Effects of Repeat Doses of Darapladib on the Pharmacokinetics (PK) of Rosuvastatin as Well as Evaluating Safety and Tolerability in Healthy Volunteers
A Two-Part, Open-label, Sequential, Double Cohort, Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Rosuvastatin When Co Administered With Darapladib in Healthy Adult Subjects
Status: Enrolling
Updated:  2/7/2013
GSK Investigational Site
mi
from
Anaheim, CA
To Estimate the Potential Effects of Repeat Doses of Darapladib on the Pharmacokinetics (PK) of Rosuvastatin as Well as Evaluating Safety and Tolerability in Healthy Volunteers
A Two-Part, Open-label, Sequential, Double Cohort, Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Rosuvastatin When Co Administered With Darapladib in Healthy Adult Subjects
Status: Enrolling
Updated: 2/7/2013
GSK Investigational Site
mi
from
Anaheim, CA
Click here to add this to my saved trials
Diabetic Macular Edema and Diabetic Retinopathy Screening (TeleMed) With Automated Retinal Photography
Diabetic Macular Edema and Diabetic Retinopathy Identification by Screening (Telemed) With Verified Automated Retinal Photography
Status: Enrolling
Updated:  2/12/2013
Craig Kadooka, MD
mi
from
Hilo, HI
Diabetic Macular Edema and Diabetic Retinopathy Screening (TeleMed) With Automated Retinal Photography
Diabetic Macular Edema and Diabetic Retinopathy Identification by Screening (Telemed) With Verified Automated Retinal Photography
Status: Enrolling
Updated: 2/12/2013
Craig Kadooka, MD
mi
from
Hilo, HI
Click here to add this to my saved trials
Effects of Weight Loss on Cardio-respiratory Function
Effects of Weight Loss on Cardio-respiratory Function and Patient-centered Outcomes in an Underserved, Minority Population With Clinically Severe Obesity
Status: Enrolling
Updated:  2/15/2013
Bellevue Hospital Ambulatory Cinic - Suite 1D
mi
from
New York, NY
Effects of Weight Loss on Cardio-respiratory Function
Effects of Weight Loss on Cardio-respiratory Function and Patient-centered Outcomes in an Underserved, Minority Population With Clinically Severe Obesity
Status: Enrolling
Updated: 2/15/2013
Bellevue Hospital Ambulatory Cinic - Suite 1D
mi
from
New York, NY
Click here to add this to my saved trials
Trial Comparison of Accuseal and Bovine Pericardial Patch During Endarterectomy
Prospective Randomized Trial Comparison of Accuseal and Bovine Pericardial Patch During Endarterectomy
Status: Enrolling
Updated:  2/18/2013
Vascular Center of Excellence
mi
from
Charleston, WV
Trial Comparison of Accuseal and Bovine Pericardial Patch During Endarterectomy
Prospective Randomized Trial Comparison of Accuseal and Bovine Pericardial Patch During Endarterectomy
Status: Enrolling
Updated: 2/18/2013
Vascular Center of Excellence
mi
from
Charleston, WV
Click here to add this to my saved trials
Feasibility and Diagnostic Accuracy of Myocardial Perfusion Imaging Using Early Imaging Protocol
Feasibility and Diagnostic Accuracy of Myocardial SPECT Using Early Imaging Protocol: A Pilot Study
Status: Enrolling
Updated:  2/18/2013
Saint Louis University School of Medicine
mi
from
Saint Louis, MO
Feasibility and Diagnostic Accuracy of Myocardial Perfusion Imaging Using Early Imaging Protocol
Feasibility and Diagnostic Accuracy of Myocardial SPECT Using Early Imaging Protocol: A Pilot Study
Status: Enrolling
Updated: 2/18/2013
Saint Louis University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Esmolol for Treatment of Perioperative Tachycardia
Safety and Efficacy of Esmolol for the Treatment of Peri-operative Tachycardia in Patients at Risk for Post Operative Adverse Ischemic Outcomes
Status: Enrolling
Updated:  2/19/2013
Duke Univ Med Ctr
mi
from
Durham, NC
Esmolol for Treatment of Perioperative Tachycardia
Safety and Efficacy of Esmolol for the Treatment of Peri-operative Tachycardia in Patients at Risk for Post Operative Adverse Ischemic Outcomes
Status: Enrolling
Updated: 2/19/2013
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Esmolol for Treatment of Perioperative Tachycardia
Safety and Efficacy of Esmolol for the Treatment of Peri-operative Tachycardia in Patients at Risk for Post Operative Adverse Ischemic Outcomes
Status: Enrolling
Updated:  2/19/2013
Durham VA Medical Center
mi
from
Durham, NC
Esmolol for Treatment of Perioperative Tachycardia
Safety and Efficacy of Esmolol for the Treatment of Peri-operative Tachycardia in Patients at Risk for Post Operative Adverse Ischemic Outcomes
Status: Enrolling
Updated: 2/19/2013
Durham VA Medical Center
mi
from
Durham, NC
Click here to add this to my saved trials
Esmolol for Treatment of Perioperative Tachycardia
Safety and Efficacy of Esmolol for the Treatment of Peri-operative Tachycardia in Patients at Risk for Post Operative Adverse Ischemic Outcomes
Status: Enrolling
Updated:  2/19/2013
Ohio State University
mi
from
Columbus, OH
Esmolol for Treatment of Perioperative Tachycardia
Safety and Efficacy of Esmolol for the Treatment of Peri-operative Tachycardia in Patients at Risk for Post Operative Adverse Ischemic Outcomes
Status: Enrolling
Updated: 2/19/2013
Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
Evaluating Two Exercise Training Programs to Reduce Leg Pain in People With Peripheral Arterial Disease (The EXERT Study)
Exercise Training to Reduce Claudication: Arm Ergometry Versus Treadmill Walking
Status: Enrolling
Updated:  2/20/2013
Univ of Minnesota
mi
from
Minneapolis, MN
Evaluating Two Exercise Training Programs to Reduce Leg Pain in People With Peripheral Arterial Disease (The EXERT Study)
Exercise Training to Reduce Claudication: Arm Ergometry Versus Treadmill Walking
Status: Enrolling
Updated: 2/20/2013
Univ of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
The Effect of Exercise Training on Skeletal Muscle Metabolism in Peripheral Artery Disease (PAD)
The Effect of Exercise Training on Skeletal Muscle Metabolism in Peripheral Artery Disease
Status: Enrolling
Updated:  2/20/2013
Brigham and Women's Hosp
mi
from
Boston, MA
The Effect of Exercise Training on Skeletal Muscle Metabolism in Peripheral Artery Disease (PAD)
The Effect of Exercise Training on Skeletal Muscle Metabolism in Peripheral Artery Disease
Status: Enrolling
Updated: 2/20/2013
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
Intravitreal Bevacizumab vs.Combination Therapy for CNV Due to Other Than AMD
Pilot Study of Intravitreal Bevacizumab vs. Combination Therapy for Choroidal Neovascularization Secondary to Causes Other Than Age-related Macular Degeneration
Status: Enrolling
Updated:  2/20/2013
Massachussetts Eye & Ear Infirmary
mi
from
Boston, MA
Intravitreal Bevacizumab vs.Combination Therapy for CNV Due to Other Than AMD
Pilot Study of Intravitreal Bevacizumab vs. Combination Therapy for Choroidal Neovascularization Secondary to Causes Other Than Age-related Macular Degeneration
Status: Enrolling
Updated: 2/20/2013
Massachussetts Eye & Ear Infirmary
mi
from
Boston, MA
Click here to add this to my saved trials
VIP Treatment in Heart Failure
VIP (Veterans Intensive Personalized) Treatment in Heart Failure
Status: Enrolling
Updated:  2/21/2013
VA New York Harbor Health Care System
mi
from
New York, NY
VIP Treatment in Heart Failure
VIP (Veterans Intensive Personalized) Treatment in Heart Failure
Status: Enrolling
Updated: 2/21/2013
VA New York Harbor Health Care System
mi
from
New York, NY
Click here to add this to my saved trials
Clopidogrel Resistance and Platelet Reactivity in Women Undergoing Percutaneous Coronary Intervention
Clopidogrel Resistance and Platelet Reactivity in Hispanic Females Undergoing Percutaneous Coronary Intervention
Status: Enrolling
Updated:  2/21/2013
University of Arizona Medical Center South Campus
mi
from
Tucson, AZ
Clopidogrel Resistance and Platelet Reactivity in Women Undergoing Percutaneous Coronary Intervention
Clopidogrel Resistance and Platelet Reactivity in Hispanic Females Undergoing Percutaneous Coronary Intervention
Status: Enrolling
Updated: 2/21/2013
University of Arizona Medical Center South Campus
mi
from
Tucson, AZ
Click here to add this to my saved trials
Clopidogrel Resistance and Platelet Reactivity in Women Undergoing Percutaneous Coronary Intervention
Clopidogrel Resistance and Platelet Reactivity in Hispanic Females Undergoing Percutaneous Coronary Intervention
Status: Enrolling
Updated:  2/21/2013
University of Arizona Medical Center University Campus
mi
from
Tucson, AZ
Clopidogrel Resistance and Platelet Reactivity in Women Undergoing Percutaneous Coronary Intervention
Clopidogrel Resistance and Platelet Reactivity in Hispanic Females Undergoing Percutaneous Coronary Intervention
Status: Enrolling
Updated: 2/21/2013
University of Arizona Medical Center University Campus
mi
from
Tucson, AZ
Click here to add this to my saved trials
Study of Exercise and Heart Function in Patients With Heart Failure and Pulmonary Vascular Disease
Evaluation of Exercise Intolerance and Right Heart Function in Patients With Heart Failure and Pulmonary Vascular Disease
Status: Enrolling
Updated:  2/25/2013
Mayo Clinic Rochester
mi
from
Rochester, MN
Study of Exercise and Heart Function in Patients With Heart Failure and Pulmonary Vascular Disease
Evaluation of Exercise Intolerance and Right Heart Function in Patients With Heart Failure and Pulmonary Vascular Disease
Status: Enrolling
Updated: 2/25/2013
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
[F-18] RGD-K5 Positron Emission Tomography (PET) in Participants With Carotid Artery Stenosis
An Exploratory, Phase II, Open Label, Single-Center, Non-Randomized Study Of [F-18] RGD-K5 Positron Emission Tomography (PET) In Participants With Carotid Artery Stenosis
Status: Enrolling
Updated:  2/25/2013
Cleveland Clinic
mi
from
Cleveland, OH
[F-18] RGD-K5 Positron Emission Tomography (PET) in Participants With Carotid Artery Stenosis
An Exploratory, Phase II, Open Label, Single-Center, Non-Randomized Study Of [F-18] RGD-K5 Positron Emission Tomography (PET) In Participants With Carotid Artery Stenosis
Status: Enrolling
Updated: 2/25/2013
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
Frequency Analysis of Coronary Artery Disease
A Single-centered Investigation Into the Frequency Domain Patterns in Vessels of Patients With Coronary Artery Disease
Status: Enrolling
Updated:  2/27/2013
University of Minnesota Medical Center (UMMC) Fairview Clinics
mi
from
Minneapolis, MN
Frequency Analysis of Coronary Artery Disease
A Single-centered Investigation Into the Frequency Domain Patterns in Vessels of Patients With Coronary Artery Disease
Status: Enrolling
Updated: 2/27/2013
University of Minnesota Medical Center (UMMC) Fairview Clinics
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) Post Approval Registry
Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy Post Approval Registry
Status: Enrolling
Updated:  2/28/2013
University of Rochester /Strong Memorial
mi
from
Rochester, NY
Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) Post Approval Registry
Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy Post Approval Registry
Status: Enrolling
Updated: 2/28/2013
University of Rochester /Strong Memorial
mi
from
Rochester, NY
Click here to add this to my saved trials
Lower Extremity Regional Anesthesia and Infrainguinal Bypass Grafting
Lower Extremity Regional Anesthesia and Infrainguinal Bypass Grafting
Status: Enrolling
Updated:  2/28/2013
Univ of Nebraska Med Ctr
mi
from
Omaha, NE
Lower Extremity Regional Anesthesia and Infrainguinal Bypass Grafting
Lower Extremity Regional Anesthesia and Infrainguinal Bypass Grafting
Status: Enrolling
Updated: 2/28/2013
Univ of Nebraska Med Ctr
mi
from
Omaha, NE
Click here to add this to my saved trials
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study in a Younger and Older Drug Refractory, Recurrent, Symptomatic Paroxysmal AF Population
Status: Enrolling
Updated:  3/4/2013
Huntsville Hospital
mi
from
Huntsville, AL
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study in a Younger and Older Drug Refractory, Recurrent, Symptomatic Paroxysmal AF Population
Status: Enrolling
Updated: 3/4/2013
Huntsville Hospital
mi
from
Huntsville, AL
Click here to add this to my saved trials
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study in a Younger and Older Drug Refractory, Recurrent, Symptomatic Paroxysmal AF Population
Status: Enrolling
Updated:  3/4/2013
Providence Alaska Medical Center
mi
from
Anchorage, AK
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study in a Younger and Older Drug Refractory, Recurrent, Symptomatic Paroxysmal AF Population
Status: Enrolling
Updated: 3/4/2013
Providence Alaska Medical Center
mi
from
Anchorage, AK
Click here to add this to my saved trials
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study in a Younger and Older Drug Refractory, Recurrent, Symptomatic Paroxysmal AF Population
Status: Enrolling
Updated:  3/4/2013
Scripps Memorial Hospital
mi
from
La Jolla, CA
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study in a Younger and Older Drug Refractory, Recurrent, Symptomatic Paroxysmal AF Population
Status: Enrolling
Updated: 3/4/2013
Scripps Memorial Hospital
mi
from
La Jolla, CA
Click here to add this to my saved trials
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study in a Younger and Older Drug Refractory, Recurrent, Symptomatic Paroxysmal AF Population
Status: Enrolling
Updated:  3/4/2013
Sharp Memorial Hospital
mi
from
San Diego, CA
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study in a Younger and Older Drug Refractory, Recurrent, Symptomatic Paroxysmal AF Population
Status: Enrolling
Updated: 3/4/2013
Sharp Memorial Hospital
mi
from
San Diego, CA
Click here to add this to my saved trials
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study in a Younger and Older Drug Refractory, Recurrent, Symptomatic Paroxysmal AF Population
Status: Enrolling
Updated:  3/4/2013
UCSF Medical Center
mi
from
San Francisco, CA
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study in a Younger and Older Drug Refractory, Recurrent, Symptomatic Paroxysmal AF Population
Status: Enrolling
Updated: 3/4/2013
UCSF Medical Center
mi
from
San Francisco, CA
Click here to add this to my saved trials
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study in a Younger and Older Drug Refractory, Recurrent, Symptomatic Paroxysmal AF Population
Status: Enrolling
Updated:  3/4/2013
JFK Medical Center
mi
from
Atlantis, FL
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study in a Younger and Older Drug Refractory, Recurrent, Symptomatic Paroxysmal AF Population
Status: Enrolling
Updated: 3/4/2013
JFK Medical Center
mi
from
Atlantis, FL
Click here to add this to my saved trials
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study in a Younger and Older Drug Refractory, Recurrent, Symptomatic Paroxysmal AF Population
Status: Enrolling
Updated:  3/4/2013
Saint Vincent's Medical Center
mi
from
Jacksonville, FL
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study in a Younger and Older Drug Refractory, Recurrent, Symptomatic Paroxysmal AF Population
Status: Enrolling
Updated: 3/4/2013
Saint Vincent's Medical Center
mi
from
Jacksonville, FL
Click here to add this to my saved trials
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study in a Younger and Older Drug Refractory, Recurrent, Symptomatic Paroxysmal AF Population
Status: Enrolling
Updated:  3/4/2013
Florida Heart Rhythm Institute
mi
from
Tampa, FL
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study in a Younger and Older Drug Refractory, Recurrent, Symptomatic Paroxysmal AF Population
Status: Enrolling
Updated: 3/4/2013
Florida Heart Rhythm Institute
mi
from
Tampa, FL
Click here to add this to my saved trials
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study in a Younger and Older Drug Refractory, Recurrent, Symptomatic Paroxysmal AF Population
Status: Enrolling
Updated:  3/4/2013
St. Josephs Hospital - Savannah
mi
from
Savannah, GA
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study in a Younger and Older Drug Refractory, Recurrent, Symptomatic Paroxysmal AF Population
Status: Enrolling
Updated: 3/4/2013
St. Josephs Hospital - Savannah
mi
from
Savannah, GA
Click here to add this to my saved trials
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study in a Younger and Older Drug Refractory, Recurrent, Symptomatic Paroxysmal AF Population
Status: Enrolling
Updated:  3/4/2013
University of Chicago Medical Center
mi
from
Chicago, IL
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study in a Younger and Older Drug Refractory, Recurrent, Symptomatic Paroxysmal AF Population
Status: Enrolling
Updated: 3/4/2013
University of Chicago Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study in a Younger and Older Drug Refractory, Recurrent, Symptomatic Paroxysmal AF Population
Status: Enrolling
Updated:  3/4/2013
Alexian Brothers Medical Center
mi
from
Elk Grove Village, IL
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study in a Younger and Older Drug Refractory, Recurrent, Symptomatic Paroxysmal AF Population
Status: Enrolling
Updated: 3/4/2013
Alexian Brothers Medical Center
mi
from
Elk Grove Village, IL
Click here to add this to my saved trials
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study in a Younger and Older Drug Refractory, Recurrent, Symptomatic Paroxysmal AF Population
Status: Enrolling
Updated:  3/4/2013
St. Johns Hospital
mi
from
Springfield, IL
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study
NAVISTAR® THERMOCOOL® SF Catheter: Observational Study in a Younger and Older Drug Refractory, Recurrent, Symptomatic Paroxysmal AF Population
Status: Enrolling
Updated: 3/4/2013
St. Johns Hospital
mi
from
Springfield, IL
Click here to add this to my saved trials